Back to Search
Start Over
The optimal duration of immune checkpoint inhibitors in non-oncogene addicted non-small cell lung cancer: less is more? An open question.
- Source :
-
Recenti progressi in medicina [Recenti Prog Med] 2021 Dec; Vol. 112 (12), pp. 802-804. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 2038-1840
- Volume :
- 112
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Recenti progressi in medicina
- Publication Type :
- Academic Journal
- Accession number :
- 34924575
- Full Text :
- https://doi.org/10.1701/3710.37003